Dr Oxentenko gives a look into the future for the treatment of celiac disease, including the potential of therapies to offer alternatives to the gluten-free diet.
Dr Oxentenko gives a look into the future for the treatment of celiac disease, including the potential of therapies to offer alternatives to the gluten-free diet.
In this episode of Gut Check, Dr Brian Lacy talks with Dr Samuel Han from the Mayo Clinic about the etiology, risk factors, diagnosis, and treatment of chronic pancreatitis.
In this episode of Gut Check, Dr Brian Lacy talks with Dr Samuel Han from the Mayo Clinic about the etiology, risk factors, diagnosis, and treatment of chronic pancreatitis.
Host Brian Lacy, MD, talks with Dr Rena Yadlapati about determining which patients may need antireflux surgery, types of surgical approaches, and possible complications.
Host Brian Lacy, MD, talks with Dr Rena Yadlapati about determining which patients may need antireflux surgery, types of surgical approaches, and possible complications.
In this episode of Gut Check, host Brian Lacy, MD, talks with Dr Ami Sperber about how disorders of gut-brain interaction can overlap, and how this can change treatment paradigms.
In this episode of Gut Check, host Brian Lacy, MD, talks with Dr Ami Sperber about how disorders of gut-brain interaction can overlap, and how this can change treatment paradigms.
Patients with concurrent celiac disease and eosinophilic esophagitis (EOE) had significantly lower odds of dysphagia and food bolus impaction compared to those with EOE alone.
Patients with concurrent celiac disease and eosinophilic esophagitis (EOE) had significantly lower odds of dysphagia and food bolus impaction compared to those with EOE alone.
Dr Brian Lacy brings Dr Douglas Drossman back to Gut Check for a follow-up podcast on disorders of gut-brain interaction, to review the use of neuromodulators in treatment.
Dr Brian Lacy brings Dr Douglas Drossman back to Gut Check for a follow-up podcast on disorders of gut-brain interaction, to review the use of neuromodulators in treatment.
In this first of a two-part podcast on Helicobacter pylori, Drs Brian Lacy and William Chey discuss the prevalence of H pylori infection and how to best diagnose the condition.
In this first of a two-part podcast on Helicobacter pylori, Drs Brian Lacy and William Chey discuss the prevalence of H pylori infection and how to best diagnose the condition.
A recent study found that the prevalence of gastrointestinal symptoms in patients hospitalized for COVID-19 is higher than has been previously reported.
A recent study found that the prevalence of gastrointestinal symptoms in patients hospitalized for COVID-19 is higher than has been previously reported.
A practical, risk-based strategy for evaluating and managing metabolic dysfunction-associated steatosis and steatohepatitis (MASLD/MASH) highlights the need for integrated care in patients with obesity and metabolic comorbidities.
A practical, risk-based strategy for evaluating and managing metabolic dysfunction-associated steatosis and steatohepatitis (MASLD/MASH) highlights the need for integrated care in patients with obesity and metabolic comorbidities.
A study presented at the American College of Gastroenterology, reveals that primary sclerosing cholangitis independently increases the risk of colorectal cancer.
A study presented at the American College of Gastroenterology, reveals that primary sclerosing cholangitis independently increases the risk of colorectal cancer.
Research on racial and economic disparities underscores the urgent need for targeted interventions to promote early detection and equitable health care access.
Research on racial and economic disparities underscores the urgent need for targeted interventions to promote early detection and equitable health care access.
The proposed adjusted postcolonoscopy colorectal cancer rate provides a more accurate and reproducible standardized benchmark while minimizing heterogeneity, the investigators concluded.
The proposed adjusted postcolonoscopy colorectal cancer rate provides a more accurate and reproducible standardized benchmark while minimizing heterogeneity, the investigators concluded.
Compared with lean patients with IBD and MASLD, overweight/obese patients with IBD and MASLD had higher levels of insulin resistance and smoking history, the study found.
Compared with lean patients with IBD and MASLD, overweight/obese patients with IBD and MASLD had higher levels of insulin resistance and smoking history, the study found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.
Vonoprazan offers an effective alternative treatment to intravenous proton pump inhibitors for prevention of rebleeding among patients with high-risk peptic ulcers, researchers found.